Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Beeler

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Gynecologic Oncology|August 23, 2005
A phase I/II trial of weekly topotecan and carboplatin in potentially platinum-sensitive relapsed ovarian and peritoneal carcinomaPeter G Rose, Mary Smrekar, Pamela Haba, et al.
Cancer Treatment and Research|March 28, 2020
New Technologies to Image TumorsGeorge McNamara, Justin Lucas, John F Beeler, et al.
Lung Cancer (Amsterdam, Netherlands)|September 14, 2019
Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancerNicolas Guibert, Greg Jones, John F Beeler, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Gynecologic Oncology|August 23, 2005
A phase I/II trial of weekly topotecan and carboplatin in potentially platinum-sensitive relapsed ovarian and peritoneal carcinomaPeter G Rose, Mary Smrekar, Pamela Haba, et al.
Cancer Treatment and Research|March 28, 2020
New Technologies to Image TumorsGeorge McNamara, Justin Lucas, John F Beeler, et al.
Lung Cancer (Amsterdam, Netherlands)|September 14, 2019
Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancerNicolas Guibert, Greg Jones, John F Beeler, et al.
Pageof 1